Sector Gamma ASA »

Denali Therapeutics shares owned by Sector Gamma ASA

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Sector Gamma ASA from 13F filings

Historical chart of Sector Gamma ASA investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Sector Gamma ASA

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 163k 19.20

More positions owned by Sector Gamma ASA

Bristol Myers Squibb (BMY)
Merck & Co (MRK)
Pfizer (PFE)
Medtronic SHS (MDT)
Incyte Corporation (INCY)
Amgen (AMGN)
Biogen Idec (BIIB)
Zimmer Holdings (ZBH)
BioMarin Pharmaceutical (BMRN)
Becton, Dickinson and (BDX)
Anthem (ELV)
Ionis Pharmaceuticals (IONS)
Cardinal Health (CAH)
UnitedHealth (UNH)
CVS Caremark Corporation (CVS)

View all positions for Sector Gamma ASA

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
Temasek Holdings
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein

View all funds holding Denali Therapeutics